Back to stocks
TARA

TARA

Protara Therapeutics, Inc.• Healthcare

Q3 2026 filings are still coming in. 13F filers have 45 days after the quarter ends to report, through November 14, 2026. These totals cover only the funds that have filed so far and will keep rising.
Institutional holders
15
Partial Q3 2026
Total 13F value
$1.3M
Filed positions so far
New positions
2
This quarter
Sold positions
4
This quarter

Top holders

Institutions with disclosed positions in this stock

FundValueShares% PortfolioChange

Oppenheimer & Co Inc

$664K217.6K0.01%-8.7%

Alps Advisors Inc

$237K77.7K0.00%+36.3%

Truist Financial Corp

$183K60.0K0.00%Unchanged

Indivisible Partners

$156K51.1K0.01%New Position

Commonwealth Equity Services, Llc

$34K11.0K0.00%Unchanged

Essential Partners Llc

$33K10.8K0.02%+10.6%

Sbi Securities Co., Ltd.

$5K1.6K0.00%+1456.3%

Sterling Capital Management Llc

$3K1.0K0.00%-2.2%

Caitong International Asset Management Co., Ltd

$3K1.0K0.00%+843.5%

Gamma Investing Llc

$2K6820.00%-6.8%

State Of Wyoming

$2K6370.00%-33.6%

Parkside Financial Bank & Trust

$1K4050.00%New Position

Aspect Partners, Llc

$7692520.00%+9.6%

Sjs Investment Consulting Inc.

$248810.00%+305.0%

Farther Finance Advisors, Llc

$180590.00%-35.9%

Explore